Canary Capital CEO Steven McClurg said he expects BlackRock could enter the spot XRP ETF race as soon as late 2026, framing it as a demand-led decision rather thanCanary Capital CEO Steven McClurg said he expects BlackRock could enter the spot XRP ETF race as soon as late 2026, framing it as a demand-led decision rather than

BlackRock XRP ETF Next? Canary CEO Eyes Late 2026

3 min read

Canary Capital CEO Steven McClurg said he expects BlackRock could enter the spot XRP ETF race as soon as late 2026, framing it as a demand-led decision rather than a sudden shift in conviction from the world’s largest asset manager.

Speaking in a Jan. 27 interview with Crypto Sensei, McClurg argued that the market is already moving in that direction as more legacy ETF issuers test the perimeter of non-Bitcoin products.

BlackRock Could Join XRP ETF Race By End Of 2026

“It wouldn’t surprise me if BlackRock files for a XRP, potentially Solana ETF sometime by the end of 2026 or 2027,” he said. “I mean you’ve already got Fidelity, you’ve already got Franklin Templeton in the race there. So it’s not going to be a whole lot longer before BlackRock. Aso […] Invesco just filed for a Solana ETF. Give it time. XRP will be there as well.”

McClurg described the ETF playbook as straightforward: issuers follow client demand and liquid market structure, then expand product shelves once the commercial case is clear. “I think it has to do with a few functions. They want to see demand. They want to see high market cap and it’ll get there eventually,” he said, suggesting that XRP’s pathway to a BlackRock filing is less about narratives and more about sustained investor pull.

That framework also matches how he says Canary thinks about filings. Asked how much product development is driven by client demand versus the firm’s own views, McClurg was blunt: “It’s highly weighted towards where we believe demand is.” He added that Canary will occasionally “take a couple of risks” on earlier-stage tokens, citing Axelar as a filing that was ultimately not launched amid weaker demand and drawdowns.

McClurg’s comments came with a wider thesis about where institutional attention is shifting. He said many pension funds and sovereign wealth investors are approaching Bitcoin as an allocation akin to gold, but that conversations around Ethereum often stall. “The conversation we’re having with Ethereum is that’s old technology, I want what’s next,” he said, adding that some institutions “just pass on Ethereum,” pointing to a view that open-source code can be replicated inside private networks.

By contrast, he said institutions are increasingly focused on networks he described as “very cheap and efficient to run,” naming XRP Ledger, Hedera, and Solana, alongside “competitors to Solana” such as Injective. The core pitch, in his telling, is operational: lower costs, higher throughput, and a clearer line from network utility to enterprise deployment.

On US bank adoption, McClurg predicted banks will partner with specific crypto protocols rather than converge on a single rail, with Ripple “first,” Hedera “second,” and Solana “a far third” in terms of being “dug into the financial system.” He also singled out Ripple’s stablecoin RLUSD as a potential breakout, saying, “I see that thing exploding” once integrated with partner rails, and even floated that RLUSD “could surpass USDC.”

McClurg tied much of the timing, ETFs included, to regulatory clarity. “I don’t really care what’s in the bill. I just want to know what I can and can’t do,” he said, referring to the Clarity Act debate. “And once I know what I can and can’t do, I can go make money […] just tell me the rules so that I can go out and run my business and not have to look over my shoulder.”

At press time, XRP traded at $1.75.

XRP price chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29